Head-to-head · Value Score
BetterMe Rx vs REMEVi
Two GLP-1 deals, scored on the same six factors. BetterMe Rx lands a Value Score of 86, REMEVi a 84. Here's who gives you the honest lower price — and where each one bites back.
BetterMe Rx
#27 · Grade A- · Great Deal
Est. first month
$199/mo
Save ~85% vs brand-nameREMEVi
#39 · Grade B+ · Good Value
Est. first month
$219/mo (all doses, compounded)
Save ~84% vs brand-nameThe verdict
BetterMe Rx takes it on Value Score, 86 to 84 — an est. $199/mo first month, with no teaser step-up baked in. REMEVi isn't out of it: Shoppers who want spanish-speaking patients wanting bilingual, LegitScript-certified compounded GLP-1.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | BetterMe Rx | REMEVi |
|---|---|---|
| Value Score | 86 (A-) | 84 (B+) |
| Est. first month | $199/mo | $219/mo (all doses, compounded) |
| Save vs brand-name | ~85% | ~84% |
| Semaglutide | $199/mo | $219/mo (all doses, compounded) |
| Tirzepatide | $299/mo | $319/mo (all doses, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
BetterMe Rx
A LegitScript-certified, all-50-state program pairing standard $199/$299 flat pricing with a lower-cost oral option.
Why it's a deal
- LegitScript-certified with all-50-state reach
- Offers an oral/sublingual route at a lower entry
- Flat pricing on both molecules — no step-up
The fine print
- $199/$299 is mid-market, not a bargain
- No brand-name access
REMEVi
REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
Why it's a deal
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
- Available in all 50 states and DC, with no minimum commitment and no cancellation fee
The fine print
- The flat rate is one of the highest entry prices in this ranking; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores BetterMe Rx is ranked on the BetterMe Rx alternatives ranking, and the same list for the other side is on alternatives to REMEVi.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.